WHO ICTRP trial
Effects of etomidate, propofol and etomidate combined with propofol on…
IRCT20231222060494N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20231222060494N1 |
|---|---|
| Public title | Effects of etomidate, propofol and etomidate combined with propofol on hemodynamic changes in high blood pressure patients |
| Scientific title | Investigating the effects of etomidate, propofol and etomidate combined with propofol injections on hemodynamic changes in high blood pressure patients who are candidates for general anesthesia |
| Primary sponsor | Ardabil University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Hemodynamic status. Elevated blood-pressure reading, without diagnosis of hypertension;R03.0 |
| Interventions | Intervention 1: Intervention group: The group receiving propofol 1.5-2 mg/kg (Tehran shimi Co). Intervention 2: Intervention group: The group receiving etomidate 0 3 mg/kg (Aboreihan Co). Intervention 3: Intervention group: The group… |
| Registration date | Jan 7, 2024 |
| Target size | 150 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: